Skip to main content

RHUMBLINE ADVISERS

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in REGN

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$121,907,911
-$2,212,644 QoQ
Shares Held
157,781
-1.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 60.45848359434913.ToString("F0")% Shared 0.ToString("F0")% None 39.541516405650874.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,828,718 across 284 Biotechnology names. REGN ranks #2 (9.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
157,781 $121,907,911

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $121,907,911 157,781
2025-12-31 $124,120,555 160,805
2025-09-30 $94,461,922 168,001
2025-06-30 $89,595,975 170,659
2025-03-31 $109,827,706 173,167
2024-12-31 $121,537,744 170,620
2024-09-30 $183,699,985 174,746
2024-06-30 $189,287,349 180,097
2024-03-31 $176,681,401 183,567
2023-12-31 $159,495,707 181,598
2023-09-30 $150,830,462 183,278
2023-06-30 $133,700,893 186,073
2023-03-31 $150,944,065 183,704
2022-12-31 $135,571,578 187,905
2022-09-30 $123,306,352 178,998
2022-06-30 $102,604,207 173,573
2022-03-31 $113,930,460 163,126
2021-12-31 $102,305,608 161,999
2021-09-30 $97,595,563 161,267
2021-06-30 $90,367,303 161,792
2021-03-31 $78,186,385 165,250
2020-12-31 $84,000,268 173,874
2020-09-30 $107,969,246 192,878
2020-06-30 $122,171,164 195,897
2020-03-31 $71,509,582 146,449